Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIK2 | Q9H0K1 | 2/20 | 0.46 |
| ▸ | CSF1R | P07333 | 1/20 | 0.43 |
| ▸ | SIK1 | P57059 | 1/20 | 0.43 |
| ▸ | SIK3 | Q9Y2K2 | 1/20 | 0.43 |
| ▸ | FGFR4 | P22455 | 15/20 | 0.33 |
| ▸ | FGFR1 | P11362 | 11/20 | 0.33 |
| ▸ | FGFR2 | P21802 | 6/20 | 0.32 |
| ▸ | FGFR3 | P22607 | 5/20 | 0.32 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | DHFR | P00374 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25882416 | 1.00 | SIK2 (0.46) | SIK2CSF1RSIK1SIK3FGFR4 | |
| SCHEMBL23978369 | 0.90 | FGFR4 (0.40) | SIK2CSF1RSIK1SIK3FGFR4 | |
| SCHEMBL30309508 | 0.90 | FGFR4 (0.40) | SIK2CSF1RSIK1SIK3FGFR4 | |
| SCHEMBL30309533 | 0.88 | SIK2 (0.51) | SIK2CSF1RSIK1SIK3FGFR4 | |
| SCHEMBL23978120 | 0.88 | SIK2 (0.51) | SIK2CSF1RSIK1SIK3FGFR4 | |
| SCHEMBL30309495 | 0.86 | SIK2 (0.47) | SIK2CSF1RSIK1SIK3FGFR4 | |
| SCHEMBL30309484 | 0.82 | SIK2 (0.71) | SIK2CSF1RSIK1SIK3FGFR4 | |
| SCHEMBL25881931 | 0.81 | CSF1R (0.60) | SIK2CSF1RSIK1SIK3FGFR4 | |
| SCHEMBL30309616 | 0.81 | CSF1R (0.60) | SIK2CSF1RSIK1SIK3FGFR4 | |
| SCHEMBL30309527 | 0.81 | SIK2 (0.53) | SIK2CSF1RSIK1SIK3FGFR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4143191-A2 | BICYCLIC KINASE INHIBITORS AND USES THEREOF | iOmx Therapeutics AG (DE) | 2023-03-08 | — | — | EP | disclosed |